Journal of Lipid Research, Vol 32, 1861-1867, Copyright © 1991 by Lipid Research, Inc.

ARTICLES

A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans

F Czubayko, B Beumers, S Lammsfuss, D Lutjohann and K von Bergmann
Department of Medicine, University of Bonn, Germany.

A simple and precise micro-method for measurement of daily fecal excretion of neutral and acidic sterols has been developed which utilizes sitostanol (24-ethyl-5 alpha-cholestane-3 beta-ol) as fecal flow and recovery marker. Extractions of sterols were performed from 50 microliters of fecal homogenate (feces-water 1:1), and analyses of neutral and acidic sterols were carried out by gas-liquid chromatography. The method is sensitive, precise, and easy to perform; the intra-assay variability yielded coefficients of variations of 1.9% and 3.5% (n = 6) for neutral and acidic sterols, respectively. The results from this method were compared with those obtained with the standard fecal flow marker chromic oxide. The correlation coefficients between the two markers were compared in 16 subjects and were 0.938 and 0.998 for excretion of neutral sterols and acidic sterols, respectively. Comparison of the fecal excretion of neutral and acidic sterols in 12 subjects determined from frozen samples and aliquots (approximately 1 g) sent by ordinary mail to the laboratory (transport time 1 to 5 days) gave identical results using sitostanol as fecal flow marker (818 +/- (SEM) 85 mg/day vs. 838 +/- 89 mg/day for neutral sterols and 417 +/- 59 mg/day vs. 414 +/- 60 mg/day for acidic sterols). The new micro-method is ideally suited for research laboratories in need of a simple, accurate, inexpensive, and high through-put method for measuring daily fecal excretion of neutral and acidic sterols, as well as total cholesterol synthesis, and can be performed on an outpatient basis.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. M. deGoma, R. L. deGoma, and D. J. Rader Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2199 - 2211. [Abstract] [Full Text] [PDF]

				J. J. Clarenbach, M. Reber, D. Lutjohann, K. von Bergmann, and T. Sudhop The lipid-lowering effect of ezetimibe in pure vegetarians J. Lipid Res., December 1, 2006; 47(12): 2820 - 2824. [Abstract] [Full Text] [PDF]

				K. von Bergmann, D. Lutjohann, B. Lindenthal, and A. Steinmetz Efficiency of intestinal cholesterol absorption in humans is not related to apoE phenotype J. Lipid Res., January 1, 2003; 44(1): 193 - 197. [Abstract] [Full Text] [PDF]

				T. Sudhop, D. Lutjohann, A. Kodal, M. Igel, D. L. Tribble, S. Shah, I. Perevozskaya, and K. von Bergmann Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans Circulation, October 8, 2002; 106(15): 1943 - 1948. [Abstract] [Full Text] [PDF]

				M. N. Nanjee, C. J. Cooke, R. Garvin, F. Semeria, G. Lewis, W. L. Olszewski, and N. E. Miller Intravenous apoA-I/lecithin discs increase pre-{beta}-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans J. Lipid Res., October 1, 2001; 42(10): 1586 - 1593. [Abstract] [Full Text] [PDF]

				K. Fassbender, M. Simons, C. Bergmann, M. Stroick, D. Lütjohann, P. Keller, H. Runz, S. Kühl, T. Bertsch, K. von Bergmann, et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo PNAS, April 5, 2001; (2001) 81620098. [Abstract] [Full Text]

				M. Chandalia, A. Garg, D. Lutjohann, K. von Bergmann, S. M. Grundy, and L. J. Brinkley Beneficial Effects of High Dietary Fiber Intake in Patients with Type 2 Diabetes Mellitus N. Engl. J. Med., May 11, 2000; 342(19): 1392 - 1398. [Abstract] [Full Text] [PDF]

				T. T. Nguyen The Cholesterol-Lowering Action of Plant Stanol Esters J. Nutr., December 1, 1999; 129(12): 2109 - 2112. [Abstract] [Full Text]

				S.-H. Bok, S.-H. Lee, Y.-B. Park, K.-H. Bae, K.-H. Son, T.-S. Jeong, and M.-S. Choi Plasma and Hepatic Cholesterol and Hepatic Activities of 3-Hydroxy-3-methyl-glutaryl-CoA Reductase and Acyl CoA: Cholesterol Transferase Are Lower in Rats Fed Citrus Peel Extract or a Mixture of Citrus Bioflavonoids J. Nutr., June 1, 1999; 129(6): 1182 - 1185. [Abstract] [Full Text]

				E. A. Trautwein, A. Kunath-Rau, and H. F. Erbersdobler Increased Fecal Bile Acid Excretion and Changes in the Circulating Bile Acid Pool Are Involved in the Hypocholesterolemic and Gallstone-Preventive Actions of Psyllium in Hamsters J. Nutr., April 1, 1999; 129(4): 896 - 902. [Abstract] [Full Text]

				M. A Hallikainen and M. I. Uusitupa Effects of 2 low-fat stanol ester–containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects Am. J. Clinical Nutrition, March 1, 1999; 69(3): 403 - 410. [Abstract] [Full Text] [PDF]

				H. K. Berthold, T. Sudhop, and K. von Bergmann Effect of a Garlic Oil Preparation on Serum Lipoproteins and Cholesterol Metabolism: A Randomized Controlled Trial JAMA, June 17, 1998; 279(23): 1900 - 1902. [Abstract] [Full Text] [PDF]

				K. Fassbender, M. Simons, C. Bergmann, M. Stroick, D. Lutjohann, P. Keller, H. Runz, S. Kuhl, T. Bertsch, K. von Bergmann, et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo PNAS, May 8, 2001; 98(10): 5856 - 5861. [Abstract] [Full Text] [PDF]